Cognition enhancers between treating and doping the mind

C Lanni, SC Lenzken, A Pascale, I Del Vecchio… - Pharmacological …, 2008 - Elsevier
Memory, attention and creativity represent three different cognitive domains, which are
interconnected and contribute the “mental performance” of an individual. Modern …

Obsessive–compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults

NA Fineberg, S Reghunandanan, HB Simpson… - Psychiatry …, 2015 - Elsevier
This narrative review gathers together a range of international experts to critically appraise
the existing trial-based evidence relating to the efficacy and tolerability of pharmacotherapy …

Defensive behaviors, fear, and anxiety

DC Blanchard, RJ Blanchard - Handbook of behavioral neuroscience, 2008 - Elsevier
Defensive behaviors are a set of responses to threat stimuli and situations that have evolved
on the basis of their adaptiveness in reducing harm to the threatened organism. These …

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

JR Nash, PA Sargent, EA Rabiner, SD Hood… - The British Journal of …, 2008 - cambridge.org
BackgroundThe importance of the neurotransmitter serotonin (5-HT) in the pathophysiology
of anxiety is well known. A key role for postsynaptic 5-HT1A receptors has recently been …

Antidepressant-induced jitteriness/anxiety syndrome: systematic review

LI Sinclair, DM Christmas, SD Hood… - The British Journal of …, 2009 - cambridge.org
BackgroundEarly worsening of anxiety, agitation and irritability are thought to be common
among people commencing antidepressants, especially for anxiety disorders. This …

[PDF][PDF] Bayesian meta-analysis with weakly informative prior distributions

DR Williams, P Rast, PC Bürkner - 2018 - osf.io
Developing meta-analytic methods is an important goal for psychological science. When
there are few studies in particular, commonly used methods have several limitations, most …

The evidence-based pharmacotherapy of social anxiety disorder

C Blanco, LB Bragdon, FR Schneier… - International Journal …, 2013 - academic.oup.com
Social anxiety disorder (SAD) is a highly prevalent and often disabling disorder. This paper
reviews the pharmacological treatment of SAD based on published placebo-controlled …

Pharmacotherapy for anxiety and comorbid alcohol use disorders

JC Ipser, D Wilson, TO Akindipe… - Cochrane Database …, 2015 - cochranelibrary.com
Background Anxiety disorders are a potentially disabling group of disorders that frequently
co‐occur with alcohol use disorders. Comorbid anxiety and alcohol use disorders are …

The German guidelines for the treatment of anxiety disorders

B Bandelow, T Lichte, S Rudolf, J Wiltink… - European archives of …, 2015 - Springer
A consensus group consisting of 36 experts representing 20 leading German specialist
societies and patient self-help organizations developed evidence-based recommendations …

Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression

RM O'connor, TG Dinan, JF Cryan - Molecular psychiatry, 2012 - nature.com
Anxiety and depression are devastating mental illnesses that are a significant public health
concern. Selective serotonin-reuptake inhibitors are the first-line treatment strategy for these …